Charles Schwab’s OpGen, Inc OPGN Stock Holding History

Charles Schwab’s Portfolio OPGN Stock Details OPGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-113	Closed	-$23K	–	3635
2021 Q4	$23K	Hold	113	–	–	﹤0.01%	3578
2021 Q3	$66K	Hold	113	–	–	﹤0.01%	3419
2021 Q2	$52K	Buy	+113	New	+$51.7K	﹤0.01%	3362

Other funds holding OPGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Charles Schwab's OPGN Position: Q1 2022 in Review

Charles Schwab sold out of OpGen, Inc (OPGN) in Q1 2022, closing a stake of 113 shares — an estimated $23K sold.

Charles Schwab first reported a position in OPGN in Q2 2021 and held it in 3 quarters. The position peaked at $66K in Q3 2021. 28 funds tracked by Wall St. Rank hold OPGN as of Q1 2022.

Charles Schwab reported no remaining OpGen, Inc position as of Q1 2022 after selling out during the quarter.
Charles Schwab sold 113 OpGen, Inc shares in Q1 2022, an estimated $23K.
Charles Schwab first reported a position in OpGen, Inc in Q2 2021 and held it in 3 quarters.
Charles Schwab's OpGen, Inc position peaked at $66K in Q3 2021.
28 funds tracked by Wall St. Rank held OpGen, Inc as of Q1 2022.

Based on Charles Schwab's 13F filing for Q1 2022, filed 13 May 2022.